Netherlands· NL-eff7e52d2df8
Teduglutide Viatris 5 mg, poeder en oplosmiddel voor oplossing voor injectie
A teduglutide product containing teduglutide, registered in Netherlands by Viatris Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Teduglutide is registered in 15 of 19 countries.
Countries holding a registration under ATC A16AX08 (teduglutide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Teduglutide · ATC A16AX08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TEDUGLUTIDE
- Manufacturer
- Viatris Limited
- Country
- Netherlands (NL)
- ATC code
- A16AX08
- ATC class
- Teduglutide
- Defined daily dose
- 5 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/25/2005
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
18 interactions on record for teduglutide.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Teduglutide · interactions on record
18 records
- 2 severe
- 16 moderate
Most severe, free to view
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- ClonazepamN03AE01moderate
- MidazolamN03AE02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Teduglutide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandRevestive 5 mg powder and solvent for solution for injectionTakeda Pharmaceuticals International AG Ireland Branch
- FranceREVESTIVE 5 mg, poudre et solvant pour solution injectableTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- SwedenNilleto 5 mg Pulver och vätska till injektionsvätska, lösningFresenius Kabi AB
- FinlandRevestiveTakeda Pharmaceuticals International AG Ireland Branch
- CzechiaREVESTIVETakeda Pharmaceuticals International AG Ireland Branch, Dublin
- BelgiumRevestive 1.25 mgTakeda Pharmaceuticals International Ireland Branch
- SpainREVESTIVE 5 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLETakeda Pharmaceuticals International Ag Ireland Branch
- IcelandRevestiveTakeda Pharmaceuticals International AG Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Tidonalle
- Spain · Teduglutida Cipla
- France · Téduglutide, Teduglutide Adalvo
- Iceland · Revestive, Teduglutide Viatris
- Liechtenstein · Revestive, Teduglutide Viatris
- Norway · Niletto, Revestive
- Sweden · Nilleto, Teduglutid Cipla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8816647-769f-4cfa-8f5d-d43a94b2e408 GET /v1/drugs/f8816647-769f-4cfa-8f5d-d43a94b2e408?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/teduglutide-viatris-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Teduglutide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134257",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
"HISTIDINE, (L-)",
"MANNITOL (D-) (E 421)",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE"
],
"substances": [
"TEDUGLUTIDE"
],
"leaflet_url": null,
"authorised_at": "2026/01/08",
"procedure_number": "EMEA/H/C/006564",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/25/2005",
"additional_monitoring": "N"
}See everything about teduglutide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.